Brain - target of arterial hypertension

Time codes:
  • 01:03

    Complications of arterial hypertension

  • 03:00

    Symptoms of brain damage against hypertension

  • 04:00

    Difficulties in identifying vascular brain damage

  • 08:10

    Therapy strategy 

  • 10:00

    Therapy targets and the choice of the drug

  • 11:25

    Mexidol® research and their results 

  • 12:27

    Step treatment regimen with Mexidol® 

  • 13:28

    A comprehensive approach to the correction of cognitive disorders

Ostroumova Olga Dmitrievna – Doctor of Medical Sciences, Professor, Head. Department of Therapy and Polymorbid Pathology named after. Academician M.S. Vovsi FSBEI DPO RMANPE Ministry of Health of Russia

Vladimir Vladimirovich ZakharovDoctor of Medical Sciences, Professor of the Department of Nervous System Diseases of the Faculty of Medicine of the First Moscow State Medical University named after I.M. Sechenov

Announcement:

Hypertension is a major risk factor for hemorrhagic and ischemic stroke. It is also one of the strongest risk factors for cognitive impairment. Neurocytoprotective therapy is a field of neurology that utilizes various medications to protect the brain. How to choose the right neurocytoprotector? It's important to consider its mechanism of action. The ideal medication should have a multimodal effect, affecting multiple processes associated with brain damage. One such medication is Mexidol®.In this video, specialists will discuss the use of Mexidol® and why Mexidol® is an important treatment option for hypertension .

Block of articles on this topic

Personal: Resolution of the Council of Experts “The possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders”
The possibilities of multimodal neuroprotection in patients with chronic brain ischemia against the background of arterial hypertension and atherosclerosis

Authors:
I.A. GRIBACHEV, T.F. POPOVA, E.V. PETROVA, A.V. ZVONKOVA

FSBEI in Novosibirsk State Medical University of the Ministry of Health of Russia

Cognitive disorders in the practice of a primary link: Focus for patients with arterial hypertension

Authors:
O.D. OSTROUMOVA, A.I. KOCHETKOV, N.A. SHATALOVA

Personal: International multicenter randomized double-tied placebo-controlled study of evaluating the effectiveness and safety of sequential therapy of patients with chronic brain ischemia drugs Mexidol® and Mexidol® Forte 250: Subanalysis results in patients with arterial hypertension

Authors:
V.V. ZAKHAROV1, O.D. OSTROUMOVA1,2, A.I. KOCHETKOV2, M.V. KLEPIKOVA2, A.I. FEDIN3

The importance of identifying and diagnosing signs of brain damage to arterial hypertension

Authors:
T.M. OSTROUMOVA, O.D. OSTROUMOVA

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com